Xtrackers CSI500 Swap UCITS ETF 1C
| Issuer: Xtrackers |
| Asset Class: Equity |
| TER: 50bps |
| Trading Currency: USD |
| Pays Income: False |
| Listing Date: 14 Aug 2024 |
| Ticker: XCSI |
| ISIN: LU2788421340 |
This investment product offers targeted exposure to the mid- and small-capitalisation segment of the Chinese A-share market. It is designed to replicate the performance of the CSI 500 Net Total Return Index, which is composed of the 500 largest and most liquid stocks listed on the Shanghai and Shenzhen exchanges after excluding the 300 largest companies that form the well-known CSI 300 Index. By focusing on this next tier of companies, the strategy provides a distinct lens on the Chinese economy, capturing businesses that are often more closely tied to domestic demand, consumption trends, and emerging industries, offering a different risk-return profile compared to large-cap focused investments.
The strategic appeal of this approach lies in its potential to tap into China's evolving economic landscape. Unlike large-cap indices, which are often heavily weighted towards state-owned enterprises and the financial sector, the mid- and small-cap universe provides greater exposure to dynamic sectors such as technology, consumer discretionary, healthcare, and advanced manufacturing. These areas are central to China's long-term policy goals of fostering innovation and transitioning towards a consumption-led growth model. This focus on the 'New China' economy can offer diversification benefits within a broader emerging markets portfolio and the potential for higher growth, driven by the country's burgeoning middle class and technological advancements.
As with any single-country emerging market investment, this strategy entails a higher degree of risk, including market volatility and sensitivity to domestic policy and regulatory changes. The use of a swap-based structure, while cost-effective for accessing this specific market, introduces counterparty risk that investors should consider. Nonetheless, for those with a long-term investment horizon and an appropriate risk tolerance, this instrument serves as a valuable tool for gaining precise exposure to a vital, and often underrepresented, segment of the world's second-largest equity market, complementing existing allocations to Chinese large-caps.
